ALZ-801
ALZ-801 is an orally administered prodrug of tramiprosate, designed with improved pharmacokinetics and tolerability. It functions as a β-amyloid anti-oligomer agent, inhibiting Aβ aggregation, and is applied in Alzheimer's disease research using in vitro and in vivo experimental models.
Product Specifications
CAS Number
1034190-08-3
Product Name Alternative
Valiltramiprosate, β Amyloid, β-amyloid peptide, βAmyloid, β-amyloid, Tramiprosate, disease, BetaAmyloid, Beta Amyloid, b Amyloid, Amyloid-β, bAmyloid, ALZ801, ALZ-801, Alzheimer, ALZ 801, Abeta, Inhibitor, inhibit
Field of Research
Neuroscience
Purity
98.00% (May vary between batches)
Solubility
DMSO:< 1 mg/mL (insoluble) ; H2O:130 mg/mL (545.53 mM)
Smiles
CC (C) [C@H] (N) C (=O) NCCCS (O) (=O) =O
Molecular Formula
C8H18N2O4S
Molecular Weight
238.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
224764-01 50 µL
P38, phosphorylated (Y182) (Mitogen-Activated Protein Kinase 14, MAP Kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-Binding Protein, CSAID-Binding Protein, CSBP, MAP Kinase MXI2, MAX-interacting Protein 2, Mitogen-Activated Protein Kinase p38 alpha, MAP Kinase p38 alpha, Stress-Activated Protein Kinase 2a, SAPK2a, MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A) discontinued
Sign In for Pricing
View Details 224764-02 100 µL
P38, phosphorylated (Y182) (Mitogen-Activated Protein Kinase 14, MAP Kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-Binding Protein, CSAID-Binding Protein, CSBP, MAP Kinase MXI2, MAX-interacting Protein 2, Mitogen-Activated Protein Kinase p38 alpha, MAP Kinase p38 alpha, Stress-Activated Protein Kinase 2a, SAPK2a, MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A) discontinued
Sign In for Pricing
View Details 
GTR15272371 1 Vial
Lentiviral mouse Brsk2 shRNA (UAS) - Lentiviral mouse Brsk2 shRNA (UAS) plasmid
Sign In for Pricing
View Details